| Features: Therapy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Regular physical activity has been shown to influence cancer risk, progression, and survivorship. While exercise is not a cure for cancer, extensive research indicates that it can help reduce the risk of developing certain types of cancer and improve outcomes and quality of life for those diagnosed. -Lowering the levels of hormones levels. -Preventing high blood levels of insulin. -Regular physical activity leads to decreased levels of inflammatory markers (such as C-reactive protein and interleukin-6). -Improving immune system function (enhancing the circulation of immune cells, including natural killer cells, T lymphocytes, and macrophages) -Reducing the time it takes for food to travel through the digestive system. -Helping to prevent obesity, which is a risk factor for many cancers. -Exercise promotes the upregulation of antioxidant defenses. Exercise simultaneously modulates multiple core cancer drivers: ↓ Insulin / IGF-1 signaling ↓ Chronic inflammation (IL-6, TNF-α baseline) ↑ Immune surveillance (NK cells, CD8⁺ T cells) ↑ Mitochondrial function and mitophagy ↓ Estrogen and androgen bioavailability ↑ Circadian stability ↓ Visceral adiposity (key endocrine organ) No supplement or single molecule does this breadth of work. Exercise, fasting, and diet work by changing the environment tumors depend on — not by poisoning the tumor. Age-stratified interpretation 1. Younger / metabolically healthy adults -Baseline IGF-1: normal–high -Exercise effect: -Systemic IGF-1 ↔ or slight ↓ -IGF-1 signaling efficiency ↑ (better receptor sensitivity) -Net effect: -Less chronic growth drive -Better metabolic control ➡ This is where IGF-1 ↓ papers usually come from. 2. Older adults (≈50–60+ years) -Baseline IGF-1: low -Exercise effect: -IGF-1 ↑ (restoration toward youthful range) -Improved GH → IGF-1 axis responsiveness -Net effect: -Muscle, bone, immune maintenance -Reduced frailty and inflammation ➡ This is where IGF-1 ↑ papers come from. 3. Cancer relevance (critical distinction) -Even when circulating IGF-1 increases in older exercisers: -Tumor IGF-1 signaling still goes DOWN, because: -Insulin sensitivity improves -IGFBP balance shifts -Inflammation drops -mTOR tone is suppressed -AMPK tone is elevated So: -Host IGF-1 ↑ ≠ tumor IGF-1 signaling ↑Exercise — Cancer vs Normal Cell Effects
Exercise — Alzheimer’s Disease & Cognitive Decline
|
| Source: |
| Type: |
| – Some studies have reported upregulated expression of certain GABA receptor subunits (e.g., GABA_A receptor subunits) in breast tumors. – Increased expression has been associated with enhanced cell proliferation and migration, with some reports linking this to a poorer prognosis. -GABAergic transmission is deficient in anxiety. -Neurons expressing GABAA α1 receptors can mediate sedation, -while those expressing GABAA α2 receptors mediate anxiolytic. -In addition, extra-synaptic GABAA α5 receptors can also regulate the activity of hippocampal pyramidal cells, thereby affecting associative temporal and spatial memory Gamma-aminobutyric acid — Gamma-aminobutyric acid is an endogenous non-protein amino acid, inhibitory neurotransmitter, metabolic intermediate, and signaling ligand commonly abbreviated GABA. As a database target, it represents changes in GABA concentration, synthesis, secretion, uptake, extracellular accumulation, or GABA-shunt utilization rather than modulation of a specific GABA receptor. GABA is synthesized from glutamate by GAD1/GAD67 and GAD2/GAD65, transported by GABA transporters, and metabolized primarily by ABAT/GABA transaminase. In cancer, GABA may be produced by tumor, neural, stromal, or immune cells and can influence proliferation, invasion, mitochondrial metabolism, β-catenin signaling, and antitumor immunity. Its biological direction is strongly tumor-, receptor-, concentration-, and compartment-dependent. Typical cancer modulation: Variable/context-dependent. GABA production, secretion, extracellular accumulation, uptake, or GABA-shunt utilization may be ↑ in tumors that exploit GABA for metabolic adaptation, β-catenin activation, growth, invasion, or immune evasion. GABA signaling may instead suppress proliferation or migration in tumors expressing inhibitory GABA receptor configurations. Normal-cell relevance: GABA generally reduces neuronal excitability through GABA receptor signaling and also regulates pancreatic, immune, gastrointestinal, vascular, and endocrine functions. In Alzheimer’s disease, reduced phasic inhibition and excessive astrocyte-derived tonic GABA may coexist in different circuits; therefore total GABA direction alone may not indicate whether GABAergic function is beneficial or pathological. Target classification: Neurotransmitter; amino-acid metabolite; signaling ligand; tumor-microenvironment mediator; metabolic substrate. |
| 4139- | Ex, | Impact of physical exercise on the regulation of brain-derived neurotrophic factor in people with neurodegenerative diseases |
| - | Review, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:171 Target#:1205 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid